IMMUNE THROMBOCYTOPENIC PURPURA
Clinical trials for IMMUNE THROMBOCYTOPENIC PURPURA explained in plain language.
Never miss a new study
Get alerted when new IMMUNE THROMBOCYTOPENIC PURPURA trials appear
Sign up with your email to follow new studies for IMMUNE THROMBOCYTOPENIC PURPURA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene-Edited immune cells take on autoimmune blood diseases
Disease control Recruiting nowThis early-stage trial tests a one-time treatment called CTX112, made from donor immune cells edited with CRISPR technology. It aims to safely control two autoimmune diseases where the body attacks its own blood cells: immune thrombocytopenia (ITP) and warm autoimmune hemolytic a…
Matched conditions: IMMUNE THROMBOCYTOPENIC PURPURA
Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for teens with rare bleeding disorder: experimental drug enters final testing
Disease control Recruiting nowThis study tests an IV drug called efgartigimod in teens aged 12 to 18 with chronic immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bruising and bleeding. The goal is to find the right dose and see if it safely raises platelet counts…
Matched conditions: IMMUNE THROMBOCYTOPENIC PURPURA
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Can a higher dose of rituximab stop ITP relapses in kids?
Disease control Recruiting nowThis study tests a stronger, more frequent dosing schedule of the drug rituximab in children and young adults (ages 1 to 21) with newly diagnosed immune thrombocytopenic purpura (ITP) who are at high risk for severe bleeding. The goal is to see if this approach can safely improve…
Matched conditions: IMMUNE THROMBOCYTOPENIC PURPURA
Phase: PHASE1 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Scientists seek immune system clues from cancer patients and healthy volunteers
Knowledge-focused Recruiting nowThis research study collects blood, bone marrow, and tissue samples from people with cancer, blood disorders, and healthy volunteers. The goal is to study how the immune system changes during different treatments, including immunotherapy and chemotherapy. By comparing samples fro…
Matched conditions: IMMUNE THROMBOCYTOPENIC PURPURA
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC